Synoptis Pharma
Facade
Synoptis Pharma THC 22%
A hybrid with a slight indica lean from Polish company Synoptis Pharma. Initially it provides mental clarity and focus, then induces calming and relaxation, owed to myrcene and linalool. Patients report stimulation and an increase in energy immediately after taking the strain.

Product information
- Producer
- Synoptis Pharma
- THC / CBD
- 22% / ≤1%
- Packaging
- 15g
- Product code (EAN/GTIN)
- No verified code in the catalogue
- GdziePoLek ID (not EAN)
- 129848
- Availability
- Unconfirmed
- Availability updated
- 12/11/2026, 21:44:58
Catalogue terpene profile
| Terpene | Profile (%) |
|---|---|
| Limonene | 21 |
| Caryophyllene | 20 |
| Myrcene | 11 |
| Linalool | 10 |
| Humulene | 8 |
| Pinene | 8 |
| Terpinolene | 5 |
| Farnesene | 5 |
| Bisabolol | 3 |
Profile values are not terpene concentrations in the flower or a batch-specific certificate of analysis (COA). Verify the product, strength, packaging and code in the current registry or product documentation before prescribing. Availability may change.
Portugal
Caryophyllene
Myrcene
Linalool
Humulene
Pinene
Terpinolene
Farnesene
Bisabolol